Marjorie Glover, David Gallai and Rachel Kurth write a monthly column in the Employee Benefit Plan Review providing expert insight into employee benefits questions. This month's article addresses questions concerning the use of FSAs to pay for over the counter drugs and the ability to self-correct 401(k) plan operational failure.
Publication
The US Supreme Court has ruled that a “pure omission” under Item 303 of Securities and Exchange Commission Regulation S–K cannot give rise to a private action for securities fraud under Section 10(b) and Rule 10b-5(b) of the Securities Exchange Act of 1934.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023
